It is well documented that sympathetic nerve activity to the muscle vasculature and to the kidneys is increased in obesity and diabetes, and this could suggest that resistin may contribute to the cardiovascular complications associated with conditions of metabolic dysfunction, as has been found for leptin. Here, LEP is linked to obesity disorder.